Belharra Therapeutics
Biotechnology, 380 Un St Ste 117, San Diego, California, 01089, United States, 51-200 Employees
Phone Number: +18*********
Who is BELHARRA THERAPEUTICS
Belharra Therapeutics, Inc. is a privately held drug discovery company whose novel photoaffinity-based chemoproteomics platform is disrupting the drug discovery paradigm. Guided by a dive...
Read More
-
Headquarters: 380 Un St Ste 117, San Diego, California, 01089, United States
-
Date Founded: 2021
-
Employees: 51-200
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 5113
Does something look wrong? Fix it. | View contact records from BELHARRA THERAPEUTICS
Belharra Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Belharra Therapeutics
Answer: Belharra Therapeutics's headquarters are located at 380 Un St Ste 117, San Diego, California, 01089, United States
Answer: Belharra Therapeutics's phone number is +18*********
Answer: Belharra Therapeutics's official website is https://belharratx.com
Answer: Belharra Therapeutics's revenue is $25 Million to $50 Million
Answer: Belharra Therapeutics's SIC: 5113
Answer: Belharra Therapeutics has 51-200 employees
Answer: Belharra Therapeutics is in Biotechnology
Answer: Belharra Therapeutics contact info: Phone number: +18********* Website: https://belharratx.com
Answer: Belharra Therapeutics, Inc. is a privately held drug discovery company whose novel photoaffinity-based chemoproteomics platform is disrupting the drug discovery paradigm. Guided by a diverse team of biotech trailblazers, Belharras proprietary noncovalent drug discovery engine is uniquely capable of identifying novel starting points for transformative medicines to address previously impossible-to-treat diseases and conditions. The companys next generation chemoproteomics platform enables Belharra scientists to identify small molecule drug candidates for any binding site, on any protein, in any conformational state, in any cell type. Originating with Christopher G. Parker, Ph.D. and John Teijaro, Ph.D. at Scripps Research and pioneers in the field of chemical biology and serial biotech founders Benjamin Cravatt, Ph.D. at Scripps Research and Stuart Schreiber, Ph.D. at the Broad Institute of MIT and Harvard, the four co-founded Belharra Therapeutics in 2021 with a $50M Series A financing from Versant Ventures and incubation at Inception Therapeutics. Belharra is headquartered in the San Francisco Bay Area with its primary lab and offices in San Diego, California.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month